RT Journal Article
SR Electronic
T1 The Impact of SARS-CoV-2 Variant to COVID-19 Epidemic in Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.25.20201558
DO 10.1101/2020.09.25.20201558
A1 S. Celaschi
YR 2020
UL http://medrxiv.org/content/early/2020/12/10/2020.09.25.20201558.abstract
AB The impact of SARS-CoV-2 dominant global lineages to COVID-19 epidemics is for the first time modeled by an adaptation of the deterministic SEIR Model. Such a strategy may be applied worldwide to predict forecasts of the outbreak in any infected country. The objective of this study is to forecast the outcome of the epidemic in Brazil as a first cohort study case. The basic modeling design takes under consideration two of SARS-CoV-2 dominant strains, and a time-varying reproduction number to forecast the disease transmission behavior. The study is set as a country population-based analysis. Brazilian official published data from February 25 to August 30 2020 was employed to adjust a couple of epidemiological parameters in this cohort study. The population-based sample in this study, 4.2 Million Brazilians during the study period, is the number of confirmed cases on exposed individuals. Model parameters were estimated by minimizing the mean squared quadratic errors. The main outcomes of the study follows: The percentage values of non-symptomatic and symptomatic COVID-19 hosts were estimated to be respectively (54 ± 9) % and (46 ± 9) %. By the end of 2020, the number of confirmed cases in Brazil, within 95% CI, is predicted to reach 6 Million (5-7), and fatalities would account for 180.103 (160–200).103. Estimated forecast obtained preserving or releasing the NPIs during the last quarter of 2020, are included. Data points for extra three weeks were added after the model was complete, granting confidence on the outcomes. In 2020 the total number of exposures individuals is estimated to reach 13 ± 1 Million, 6.2% of the Brazilian population. Regarding the original SARS-CoV-2 form and its variant, the only model assumption is their distinct incubation rates. The variant SARS-CoV-2 form, as predicted by the SEIR adopted model, reaches a maximum of 96% of exposed individuals as previously reported for South America. By the end of 2020, a fraction in the range of 15–35 percentages of susceptible Brazilian individuals is to be depleted. Sufficient depletion of susceptibility (by NPIs or not) has to be achieved to weaken the global dynamics spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was granted by the financial support from FUNTTEL. Financial grant # 01.16.0053.01 FINEP/MCTI from the Brazilian Ministry of Science Communications and Innovation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This research was conducted using only data publicly available such that individual subjects cannot be identified in any way.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is already published and the sources are added to manuscript reference section. All relevant ethical guidelines have been followed. https://covid.saude.gov.br/